Glenmark Pharmaceuticals Inc., USA (Glenmark), has been granted tentative approval by the United States Food & Drug Administration for Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg, the generic version of Savella Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg of Allergan Sales, LLC. Glenmark Pharma's stock is trading higher by 0.4% on BSE at Rs 867.4/share.